FR2623811B1 - Procede de preparation d'acides phosphiniques utilises pour preparer des inhibiteurs de l'enzyme de conversion de l'angiotensine, et intermediaires ainsi obtenus - Google Patents

Procede de preparation d'acides phosphiniques utilises pour preparer des inhibiteurs de l'enzyme de conversion de l'angiotensine, et intermediaires ainsi obtenus

Info

Publication number
FR2623811B1
FR2623811B1 FR888812769A FR8812769A FR2623811B1 FR 2623811 B1 FR2623811 B1 FR 2623811B1 FR 888812769 A FR888812769 A FR 888812769A FR 8812769 A FR8812769 A FR 8812769A FR 2623811 B1 FR2623811 B1 FR 2623811B1
Authority
FR
France
Prior art keywords
preparation
intermediates
enzyme inhibitors
acids used
phosphinic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR888812769A
Other languages
English (en)
Other versions
FR2623811A1 (fr
Inventor
Edward W Petrillo Jr
Donald S Karanewsky
John K Thottathil
James E Heikes
John A Grosso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2623811A1 publication Critical patent/FR2623811A1/fr
Application granted granted Critical
Publication of FR2623811B1 publication Critical patent/FR2623811B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32Esters thereof
    • C07F9/3258Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3264Esters with hydroxyalkyl compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32Esters thereof
    • C07F9/3205Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211Esters of acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR888812769A 1987-09-30 1988-09-29 Procede de preparation d'acides phosphiniques utilises pour preparer des inhibiteurs de l'enzyme de conversion de l'angiotensine, et intermediaires ainsi obtenus Expired - Lifetime FR2623811B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/102,694 US4873356A (en) 1987-09-30 1987-09-30 Method for preparing phosphinic acids used in preparing ace inhibitors and intermediates produced thereby

Publications (2)

Publication Number Publication Date
FR2623811A1 FR2623811A1 (fr) 1989-06-02
FR2623811B1 true FR2623811B1 (fr) 1991-11-15

Family

ID=22291193

Family Applications (1)

Application Number Title Priority Date Filing Date
FR888812769A Expired - Lifetime FR2623811B1 (fr) 1987-09-30 1988-09-29 Procede de preparation d'acides phosphiniques utilises pour preparer des inhibiteurs de l'enzyme de conversion de l'angiotensine, et intermediaires ainsi obtenus

Country Status (12)

Country Link
US (1) US4873356A (fr)
JP (1) JP2716746B2 (fr)
KR (1) KR890005133A (fr)
CN (1) CN1032443A (fr)
CA (1) CA1336433C (fr)
DE (1) DE3833082A1 (fr)
FI (1) FI884200A (fr)
FR (1) FR2623811B1 (fr)
GB (1) GB2210370B (fr)
HU (1) HU205126B (fr)
IE (1) IE61587B1 (fr)
IT (1) IT1226859B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008399A (en) * 1990-01-19 1991-04-16 E. R. Squibb & Sons, Inc. Diastereoselective preparation of phosphinate esters
US6384022B1 (en) * 1996-06-17 2002-05-07 Guilford Pharmaceuticals Inc. Prodrugs of NAALAdase inhibitors
DE60106497D1 (de) * 2001-04-30 2004-11-18 Lupin Lab Ltd Ein verfahren zur herstellung von natrium fosinopril
KR100690647B1 (ko) 2004-07-29 2007-03-09 엘지전자 주식회사 바스켓 승강장치를 구비한 냉장고
CN100497335C (zh) * 2005-10-27 2009-06-10 上海医药工业研究院 取代氧膦基乙酸的光学拆分方法
CN100488969C (zh) * 2005-10-27 2009-05-20 上海医药工业研究院 光学活性的取代氧膦基乙酸盐及其用途
IT1394407B1 (it) * 2009-05-25 2012-06-15 Dipharma Francis Srl Procedimento per la preparazione di fosinopril e suoi intermedi
IT1406151B1 (it) 2010-12-06 2014-02-14 Dipharma Francis Srl Procedimento per la preparazione di fosinopril e suoi intermedi

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396772A (en) * 1981-11-23 1983-08-02 F. R. Squibb & Sons, Inc. Phosphinylalkanoyl amino acids
US4448772A (en) * 1982-04-22 1984-05-15 E. R. Squibb & Sons, Inc. Phosphinylmethylaminocarbonyl imino acid compounds useful for treating hypertension
US4468519A (en) * 1982-06-14 1984-08-28 E. R. Squibb & Sons, Inc. Esters of phosphinylalkanoyl substituted prolines
US4602092A (en) * 1983-09-19 1986-07-22 E. R. Squibb & Sons, Inc. Method for making phosphinic acid intermediates

Also Published As

Publication number Publication date
IE61587B1 (en) 1994-11-16
IT8822122A0 (it) 1988-09-29
FI884200A (fi) 1989-03-31
GB8822596D0 (en) 1988-11-02
GB2210370B (en) 1992-01-15
FR2623811A1 (fr) 1989-06-02
FI884200A0 (fi) 1988-09-13
US4873356A (en) 1989-10-10
IT1226859B (it) 1991-02-19
JP2716746B2 (ja) 1998-02-18
HUT48632A (en) 1989-06-28
CN1032443A (zh) 1989-04-19
GB2210370A (en) 1989-06-07
CA1336433C (fr) 1995-07-25
JPH01106894A (ja) 1989-04-24
DE3833082A1 (de) 1989-04-13
HU205126B (en) 1992-03-30
KR890005133A (ko) 1989-05-13
IE882938L (en) 1989-03-30

Similar Documents

Publication Publication Date Title
FR2572406B1 (fr) Procede pour la preparation d'acides diphosphoniques
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
PT81990A (fr) Procede pour l'obtention de derives peptidiques inhibiteurs de la renine et des proteases acides
FR2603899B1 (fr) Procede perfectionne pour l'expression de recombinants
FR2603361B1 (fr) Raccord double pour la jonction amovible de canalisations jumelees
NO880162L (no) Fremgangsmaate ved fremstilling av nye peptidaseinhibitorer
HK1000037A1 (en) 5(and/or6)substituted 2-(2-imidazolin-2-yl)nicotinic acids esters and salts useful as herbicidal agents and intermediates for the preparation of said nicotinic acids esters and salts
FR2623811B1 (fr) Procede de preparation d'acides phosphiniques utilises pour preparer des inhibiteurs de l'enzyme de conversion de l'angiotensine, et intermediaires ainsi obtenus
FR2609474B1 (fr) Procede de synthese electrochimique d'acides carboxyliques
MC1913A1 (fr) Procede de preparation de peptides et peptides ainsi obtenus
FR2531453B1 (fr) Procede pour determiner l'activite des enzymes
FR2576107B1 (fr) Procede de recherche d'anticorps et equipement ou kit pour la mise en oeuvre de ce procede
FR2577559B1 (fr) Procede pour l'homopolymerisation anionique d'alpha-trifluoromethylacrylate
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
DZ2619A1 (fr) Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoïques substitués.
MA24831A1 (fr) Procede pour la preparation d'acides hydroxamiques
FR2757179B1 (fr) Procede de preparation d'amides de l'acide acrylique ou methacrylique
DZ2423A1 (fr) Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoiques substitués.
BE885661A (fr) Procede pour la cyclisation d'esters d'acides alpha-chlorocarboxyliques et produits obtenus
FR2589880B1 (fr) Procede pour l'expression de genes par bacillus brevis
FR2583419B1 (fr) Procede pour la preparation de 2-bromo-a-ergocryptine et ses sels d'addition d'acides.
FR2561645B1 (fr) Procede de preparation d'acides hydroxyalkylaminoacetiques
IT1191679B (it) Processo per l'affinazione di ghisa fosforosa
BE885731A (fr) Procede pour la preparation d'iminodiacetonitrile et iminodiacetonitrile ainsi produit
FR2577222B1 (fr) Procede pour la preparation de l'acide 1-(3-mercapto-25-methylpropionyl)-pyrrolidine-(25)-carboxylique